Literature DB >> 23295961

Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?

Krystyna Pawlak1, Michal Mysliwiec, Dariusz Pawlak.   

Abstract

AIMS: Dyslipidemia and oxidative stress are commonly present in patients during maintenance dialysis treatment. However, the significance of oxidized LDL (oxLDL) as a marker of oxidative stress in uremia is still unresolved. The aim of this study was to establish the role of oxLDL and oxLDL/LDL ratio as markers of lipoprotein abnormalities and oxidative stress in the dialyzed patients. MAIN
METHODS: Plasma oxLDL level was measured by ELISA, and oxLDL/LDL ratio was calculated in 106 dialyzed patients and 20 controls. The linkages between oxLDL, oxLDL/LDL ratio and lipid profile and oxidative stress markers malondialdehyde (MDA) and Cu/Zn superoxide dismutase (Cu/Zn SOD) levels were also analyzed. KEY
FINDINGS: OxLDL levels and oxLDL/LDL ratio were similar in hemodialyzed patients and controls, whereas these parameters were lower in peritoneally dialyzed patients when compared to healthy individuals. In contrast, both MDA and Cu/Zn SOD levels were significantly higher in uremics than in controls. oxLDL and oxLDL/LDL ratio positively correlated with lipid profile (except of HDL), whereas there were no positive associations between these parameters and both MDA and Cu/Zn SOD. Multiple regression analysis confirmed that increased oxLDL/HDL and TC/HDL ratios and total cholesterol levels are the parameters which independently predicted oxLDL in dialyzed patients. In the case of oxLDL/LDL ratio, the independent variables were oxLDL/HDL ratio, total cholesterol and HDL levels. SIGNIFICANCE: oxLDL levels and oxLDL/LDL ratio seem to be the markers of lipoprotein abnormalities rather than the markers of oxidative stress in the population of dialyzed patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295961     DOI: 10.1016/j.lfs.2012.12.002

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

2.  Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy.

Authors:  Anna Tavridou; Anastasia Georgoulidou; Athanasios Roumeliotis; Stefanos Roumeliotis; Efstathia Giannakopoulou; Nikolaos Papanas; Ploumis Passadakis; Vangelis G Manolopoulos; Vassilis Vargemezis
Journal:  J Diabetes Res       Date:  2015-05-12       Impact factor: 4.011

3.  Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.

Authors:  Alessandro Fulgenzi; Rachele De Giuseppe; Fabrizia Bamonti; Maria Elena Ferrero
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

4.  Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes.

Authors:  Shailesh Kumar Samal; Abdul Rashid Qureshi; Mizanur Rahman; Peter Stenvinkel; Johan Frostegård
Journal:  J Clin Med       Date:  2020-03-11       Impact factor: 4.241

5.  Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.

Authors:  Fatemeh Pourteymour Fard Tabrizi; Fatemeh Hajizadeh-Sharafabad; Maryam Vaezi; Hamed Jafari-Vayghan; Mohammad Alizadeh; Vahid Maleki
Journal:  J Ovarian Res       Date:  2020-01-31       Impact factor: 4.234

6.  Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes.

Authors:  Takahiro Kuwashiro; Kazuhiro Tanabe; Chihiro Hayashi; Tadataka Mizoguchi; Kota Mori; Juro Jinnouchi; Masahiro Yasaka; Yasushi Okada
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

Review 7.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

8.  Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors:  Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

9.  Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population.

Authors:  Molly E Harmon; Matthew J Campen; Curtis Miller; Chris Shuey; Miranda Cajero; Selita Lucas; Bernadette Pacheco; Esther Erdei; Sandy Ramone; Teddy Nez; Johnnye Lewis
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

10.  Alterations in conformational state of albumin in plasma in chronic hemodialyzed patients.

Authors:  Anna Pieniazek; Lukasz Gwozdzinski; Zbigniew Zbrog; Krzysztof Gwozdzinski
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.